Home Cart Sign in  
Chemical Structure| 196309-76-9 Chemical Structure| 196309-76-9

Structure of BAY 11-7085
CAS No.: 196309-76-9

Chemical Structure| 196309-76-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BAY 11-7085 (BAY 11-7083) is an inhibitor of NF-κB activation and IκBα phosphorylation; it stabilizes IκBα with an IC50 of 10 μM.

Synonyms: BAY 11-7083

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BAY 11-7085

CAS No. :196309-76-9
Formula : C13H15NO2S
M.W : 249.33
SMILES Code : N#C/C=C/S(=O)(C1=CC=C(C(C)(C)C)C=C1)=O
Synonyms :
BAY 11-7083
MDL No. :MFCD01862602
InChI Key :VHKZGNPOHPFPER-ONNFQVAWSA-N
Pubchem ID :5353432

Safety of BAY 11-7085

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of BAY 11-7085

pyroptosis
TLR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
NF-κB/luc primary lung cells 1 μM 24 hours Inhibited NF-κB activation and decreased cell viability PMC514581
Huh-7 cells 5 µmol/L 2 hours Blocked TNF-α-induced up-regulation of RAP1 protein PMC5993152
PLC5 cells 5 µmol/L 2 hours Blocked TNF-α-induced up-regulation of RAP1 protein PMC5993152

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice NF-κB/luc transgenic mice Intraperitoneal injection 30 mg/kg Once daily for 3 weeks Inhibited NF-κB activation and decreased lung pI-κBα and Bcl-2 protein levels PMC514581
Mice Hepatoma xenograft model Intraperitoneal injection 20mg/kg Once daily for 14 days BAY 11-7085 attenuated PDIA3P1-induced resistance to Dox treatment and reduced nuclear translocation of NF-κB/p65. PMC7318625

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.01mL

0.80mL

0.40mL

20.05mL

4.01mL

2.01mL

40.11mL

8.02mL

4.01mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories